• OPEN AN ACCOUNT
Indian Indices
Sensex
72,631.29 -402.49
( -0.55%)
Global Indices
Nasdaq
51,707.15 -164.40
(-0.32%)
Dow Jones
7,828.98 0.74
(0.01%)
Hang Seng
67,780.30 2.78
(0.00%)
Nikkei 225
10,649.29 -6.99
(-0.07%)
Forex
USD-INR
95.69 -0.76
(-0.79%)
EUR-INR
107.00 -1.04
(-0.96%)
GBP-INR
126.57 -1.05
(-0.82%)
JPY-INR
0.60 -0.01
(-0.89%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
40.56
42927.49
EPS(TTM)
Face Value()
Div & Yield %
62.48
10
2.25
 

CARE Ratings consolidated net profit rises 23.98% in the March 2026 quarter
May 14,2026
Net profit of CARE Ratings rose 23.98% to Rs 52.83 crore in the quarter ended March 2026 as against Rs 42.61 crore during the previous quarter ended March 2025. Sales rose 19.17% to Rs 130.67 crore in the quarter ended March 2026 as against Rs 109.65 crore during the previous quarter ended March 2025.

For the full year,net profit rose 24.73% to Rs 171.18 crore in the year ended March 2026 as against Rs 137.24 crore during the previous year ended March 2025. Sales rose 17.59% to Rs 473.07 crore in the year ended March 2026 as against Rs 402.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales130.67109.65 19 473.07402.32 18
OPM %46.4943.20 -41.7338.61 -
PBDT75.8361.95 22 249.73203.99 22
PBT72.0158.89 22 235.35192.27 22
NP52.8342.61 24 171.18137.24 25